Oncology
News from the FDA/CDC
Lorcaserin withdrawn from U.S. market due to cancer risk
The Food and Drug Administration advised health care professionals to stop prescribing and dispensing lorcaserin and to contact patients who are...
Conference Coverage
Data emerging to support personalized nutrition in oncology
SAN DIEGO – Fasting has been linked to improvements in chemotherapy efficacy and decreased side effects.
News
Funding failures: Tobacco prevention and cessation
Most states fall far below minimum spending guidelines, according to American Lung Association.
News
Uptick in lung cancer in younger women, not related to smoking
Historically, lung cancer rates have been higher in men, but a new study shows higher rates in women.
Conference Coverage
Multiomics blood test outperforms other tests for colorectal cancer screening
SAN FRANCISCO – A multiomics test detected stage I and II colorectal cancer with 94% sensitivity and specificity, outperforming a fecal...
News
RCT confirms CT scan screening catches lung cancer early
CT screening of older people with heavy smoking histories – using lesion volume, not diameter, as a trigger for further work-up – reduced lung...
News
Carbs, fat, and mortality: Types matter more than levels
News
Adult survivors of childhood cancer are experiencing fewer major cardiac events
Reduced radiation exposure is a likely contributor to the improved cardiovascular outcomes.
News
European marketing of Picato suspended while skin cancer risk reviewed
The Food and Drug Administration is gathering information to investigate the safety concern raised in Europe.
News
FDA warns of possible cancer risk with lorcaserin
Results from a clinical trial assessing the drug’s safety showed the possible risk increase.